Registered outcomes12

Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.

1 to 12 of 12

List	Outcome	Time frame	Description
Primary	Determine the incidence of AE/SAEs after treatment with eculizumab and IVIg compared to placebo controls	6 months	Primary safety endpoint
Primary	Improvement of one or more grade in functional outcome (on the 6 point GBS disability scale) at 4 weeks	4 weeks	Primary efficacy endpoint
Secondary	Ability to walk unaided (GBS disability score 2) at 8 weeks	8 weeks
Secondary	Time taken to improve by at least one grade (on the GBS disability scale)	8 weeks
Secondary	Time taken to walk independently	1 year
Secondary	Difference in GBS disability score at maximum disability completed with 6 months	6 months
Secondary	Percentage of patients with a clinically relevant improvement in R-ODS score	6 months	An increase from Baseline in R-ODS score by at least 6 points on the centile metric score at 4 weeks and 6 months
Secondary	Percentage of patients with a clinically relevant improvement in ONLS	6 months	Defined as an increase from baseline in ONLS score by at least 1 point at 4 weeks and 6 months
Secondary	Requirement for ventilatory support (GBS disability score 5)	4 weeks
Secondary	Duration of ventilatory support	8 weeks
Secondary	Occurrence of relapse	2 years
Secondary	Dearth within the first 6 months	6 months

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT02029378/registered